Revolutionizing Asthma Treatment: The K-Haler

Mundipharma's Innovative Inhaler Wins Prestigious A' Design Award

The inspiration for the k-haler came from the realization that many asthma patients struggle to inhale sufficiently hard and fast with their dry powder inhalers, leading to poor asthma control. This issue has persisted since the invention of the first pressurised metered dose inhaler in 1956. Mundipharma's k-haler aims to address this problem by eliminating the need for patients to coordinate their breathing, thus making it easier for them to receive optimal drug delivery.

The k-haler's unique properties include a breath-triggered valve that automatically releases a dose when patients breathe in. This unique valve removes the need for coordination during inhalation. The device is also compact and easy to carry, with a closed system that prevents dirt from clogging the device and irritating airways. The counter mechanism displays individual doses from 120 to zero, and coloured warnings provide a week's notice for refills. A full red bar indicates when the device is empty.

The k-haler was designed and developed by Mundipharma and key partners, including Clinical Designs Limited, at their Cambridge facility in the UK. The design process involved multiple qualitative design research sessions across key European markets with patients and clinicians. These sessions were used to improve general device usage such as priming, handling, and orientation.

The k-haler's design is not only functional but also aesthetically pleasing. The main label creates the counter window and its design helps the k-haler feel clean and simple, while also aiding orientation. The labels are tamper-evident and allow for the upgrade of colourways, regulatory information, and branding.

Studies show that patients are able to use the device within 15 minutes, irrespective of age. The pack reveals information in a controlled order, and an interactive web training tool aids correct usage. The colour enables easy identification, important for patients with multiple medications. The k-haler is a truly world-class device that combines modern, user-friendly design with clever engineering.

In conclusion, Mundipharma's k-haler is a revolutionary inhaler that addresses the challenges faced by asthma patients. Its breath-activated design, ease of use, and compact size make it a game-changer in the field of asthma treatment. The k-haler's recognition with the Platinum A' Medical Devices and Medical Equipment Design Award in 2018 is a testament to its innovative design and potential to improve the lives of asthma patients worldwide.